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Abstract
Aims/introduction: We compared the diagnostic performance and correlation
between salivary, serum and capillary blood glucose of diabetes and non-diabetes
patients. Early detection of diabetes mellitus (DM) contributes to the prevention
of complications and management.
Materials and methods: This case-control study was conducted among a total of
138 participants comprising 79 newly diagnosed diabetes patients (cases) and 59
non-diabetes patients (controls). Fasting salivary glucose (FSLG), fasting serum
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glucose (FSEG) levels and fasting capillary whole blood glucose (FCWBG) level
were assayed for each participant.
Results: The mean FSLG, FSEG and FCWBG levels were significantly higher
among the cases compared to controls (p < 0.0001). There was a significant
mean difference between the levels of FSLG vs. FSEG (p < 0.0001) and FSLG
vs. FCWBG (p < 0.0001) but not levels of FSEG vs. FCWBG (p > 0.05) in
both cases and controls. A positive correlation was observed between FSLG and
FSEG (r ¼ 0.89; p < 0.0001) and FCWBG (r ¼ 0.87; p < 0.0001). At the cut-
off value >6.8 mmol/l for FSEG, a sensitivity of 99%, specificity of 100.0% and
area under the curve (AUC) of 98.8% was observed for predicting DM while a
sensitivity of 80%, specificity of 95% and AUC of 91.0% was observed for
FSLG at a cut-off value >0.5 mmol/l. At the cut-off value >6.9 mmol/l for
FCWBG, a sensitivity of 100.0%, specificity of 100.0% and AUC of 100.0% was
observed for predicting DM.
Conclusion: Fasting salivary glucose (FSLG) levels increased with increasing
blood glucose levels. However, it does not generate enough diagnostic and
predictive accuracy compared to capillary whole blood glucose which less invasive.
Keywords: Medicine, Metabolism
1. Introduction
Diabetes Mellitus (DM) is a metabolic disorders characterised by relative or absolute
insufficiency of insulin secretion and or concomitant resistance to insulin [1]. The
world prevalence of diabetes mellitus among general adults was 6.4% in 2010,
affecting 285 million adults, and is expected to increase to 7.7% by 2030, affecting
439 million adults [2]. This indicates that, there will be a 69% increase in numbers of
adults with DM between 2010 and 2030 [2].
Early diagnosis of type II DM has been suggested as an important strategy to lower
the incidence of this disease worldwide [3].
To date, urine and blood tests are widely and readily available for screening, prog-
nosis, diagnosis and monitoring DM across the globe [4]. However, the estimation of
glucose levels using urine and blood samples are associated with several challenges.
For instance, urine glucose positivity cannot be detected in early stages but at
advanced stage of DM [4]. On the other hand, venous blood sampling is more inva-
sive while capillary blood sampling can be slightly invasive, thus making patients
feel inconvenience and uncomfortable. Additionally, blood collection using needles
or lancets disturb daily life, cause nervousness and are difficult to do in long-term
diabetes patients due to development of finger lumps, risk of infection and poor
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peripheral circulation [5]. There is the need to use a more convenient and comfort-
able sampling procedure which is non-invasive, reliable and requires less expertise.
From the diagnostic point of view, the use of saliva samples in glucose estimation
have been well-documented and recommended [6, 7, 8]. Human saliva reflects the
body’s health and can indicate local and systemic alterations such that the compo-
nents of saliva can be related to the metabolic state of the individual [9]. Not only
can it be used for large scale screening program but it’s also non-invasive, and
does not require specialised skills. Recent studies have focused on the development
of saliva-based tests for screening or monitoring systemic diseases, including dia-
betes mellitus [10, 11]. Several studies have found an association between salivary
glucose and blood glucose [12, 13, 14, 15].
Although few studies conducted in Sub-Saharan Africa (SSA) estimated salivary
glucose for the diagnosis and monitoring of diabetes mellitus, it has not been studied
in the Ghanaian population, to the best of our knowledge. In addition, evaluation of
diagnostic and predictive performance of fasting salivary glucose levels with blood
glucose levels has not been studied in together among DM patients in a Ghanaian
population. This study compared the diagnostic performance and correlation of sali-
vary glucose to serum glucose and capillary blood glucose among diabetes patients
and non-diabetes patients in a Ghanaian population.
2. Materials and Methods
2.1. Study design/study site
This was a case-control study conducted at the Methodist Faith Healing Hospital
in the Afigya Kwabre of the Ashanti region, Ghana. This hospital is a referral hos-
pital for almost 20 health facilities in the district including clinics, Community-
based Health Planning and Services (CHPS) centers, maternity homes and private
hospitals. Participants for this study were recruited from September 2016 to March
2017.
2.2. Ethical consideration
Approval for this study was obtained from the Institutional Review Board (IRB) of
the University of Cape Coast and the Ethic Committee of the Methodist Faith Heal-
ing Hospital. Written informed consents was obtained from all participants. Confi-
dentiality of all participants was assured.
2.3. Study population/participants selection
A total of 138 participants aged 30e79 years who had fasted for 8e12 h prior to
sample collection were recruited for this study. Seventy-nine (79) newly diagnosed
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diabetic patients were recruited as cases and age-and-sex matched 59 healthy non-
diabetes voluntary blood donors were recruited as controls. Demographic informa-
tion was obtained from participants after written informed consent and ethical
approval. All eligible participants were adequately informed of procedures, risk
and benefits involved.
Pregnant women, patients who had taken any medication the morning before blood
sampling, mentally unstable and patients who were very ill to comply with proced-
ures of testing were excluded.
2.4. Fasting capillary whole blood glucose (FCWBG)
measurement
Capillary whole blood was obtained from the index finger of all participants. The
patient’s finger was pricked with a disposable needle and a drop of blood was
collected by applying slight pressure to the finger. The blood (2mL) was placed on
a reactive test strip for glucose and the concentration of glucose was determined us-
ing a glucometer (an ACCU-CHEK ACTIVE glucometer strip). Briefly, glucose in
the blood sample is converted to gluconolactone by glucose dehydrogenase in the
strip. This releases two (2) electrons that react with a coenzyme (PQQ)
electron acceptor. The resultant reaction creates a harmless electrical current which
is interpreted as http://www.scialert.net/asci/result.php?searchin¼Keywords&cat¼
&ascicat¼ALL&Submit¼Search&keyword¼bloodþglucose blood glucose on the
screen of the glucometer. The blood glucose was expressed in milli mole per liter
(mmol/L). According to the manufacturer, the test can accurately measure glucose
levels from 0.3 mmol/L to 33.3 mmol/L [16].
2.5. Fasting serum and saliva glucose measurements
Three (3) milliliter (ml) fasting venous blood was drawn from all participants in
the morning by trained personnel after 8e12 h overnight fast. Simultaneously,
unstimulated whole saliva samples were collected into clean plastic saliva collec-
tion containers using the spitting method as described by Wang et al. [17]. The
unstimulated whole saliva and blood samples were centrifuged at 3000rpm for 10
minutes and the supernatants were obtained for estimation of glucose. Reagent
for glucose estimation were purchased from ELITech Diagnostic (Envoy 500
Glucose Reagent Kits by ELITech Group). Fasting salivary and serum glucose
levels was estimated spectrophotometrically using the automatic clinical chemis-
try analyser (Mindray 3000 automated chemistry analyzer). Glucose determina-
tion was based on endpoint glucose oxidase peroxidase (GOD-POD) method
[16].
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2.6. Statistical analysis
Data was entered in an excel worksheet and analyzed using the statistical package for
social sciences (SPSS) version 24.0. Independent sample t-test was used for compar-
ison between two means while one-way ANOVA followed by Bonferroni multiple
comparison test was used for comparison between more than two means. Chi square
analysis was performed for comparison between categorical variables. Data was ex-
pressed as means SD, and frequency (percentage). Receivers operating character-
istics (ROC) analysis was employed to determine the sensitivity and specificity of
salivary, serum and whole blood glucose test while correlation coefficient were per-
formed to determine the relationship between salivary serum and whole blood
glucose in study population. p < 0.05 were considered statistically significant.
3. Results
The mean age of the participants was 53.61 years and a higher proportion (26.1%)
were 60e69 years. There was no significantly different between the mean ages of
the diabetes compared to non-diabetes mellitus participants (53.65  12.30 vs.
53.56  13.33years; p ¼ 0.969). Most (58%) of the participants were females
compared to males (42.0%). The means of levels of FSLG, FSEG and FCWBG
were significantly higher among the diabetes patients compared to non-diabetes pa-
tients (p < 0.001) Table 1.
Table 1. General characteristics of study participants.
Parameters Total Diabetics Non-diabetics p-value
(n [ 138) (n [ 79) (n [ 59)
Age (years) 53.61  12.70 53.65  12.30 53.56  13.33 0.969
Age group 0.661
30e39 25 (18.1) 13 (16.5) 12 (20.3)
40e49 33 (23.9) 20 (25.3) 13 (22.0)
50e59 31 (22.5) 19 (24.1) 12 (20.3)
60e69 36 (26.1) 21 (26.6) 15 (25.4)
70e79 13 (9.4) 6 (7.6) 7 (11.9)
Sex 0.944
Male 58 (42.0) 33 (41.8) 25 (42.4)
Female 80 (58.0) 46 (58.2) 34 (57.6)
FSEG (mmol/l) 11.16  6.99 15.83  5.75 4.90  1.23 <0.0001
FSLG (mmol/l) 0.67  0.45 0.92  0.43 0.32  15.70 <0.0001
FCWBG (mmol/l) 11.06  6.84 15.63  5.62 5.64  1.21 <0.0001
Values are presented as frequency (percentage), and mean  SD. FSEG: fasting serum glucose; FSLG:
fasting salivary glucose; FCWBG: fasting capillary whole blood glucose.
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As shown in Fig. 1a and b, the mean FSEG and FCWBG were significantly higher
compared to salivary glucose in both the cases (p < 0.0001) and controls (p <
0.0001). However, no significant difference was found between mean FSEG and
FCWBG concentrations in both groups (p > 0.05) (Fig.1a and b).
As shown in Table 2, There was a significant mean difference and a strong effect size
between the FSEG and FSLG and that between the FCWBG and FSLG levels in
both cases (p < 0.0001) and control participants (p < 0.0001). There was no statis-
tically significant mean difference between FSEG and FCWBG levels in both dia-
betes (bias ¼ 0.160; p ¼ 0.974) and non-diabetes patients (bias ¼ -0.005; p ¼
0.978). The effect size (Cohen d) between the mean difference in the FSEG and
Fig.1. Comparison of glucose concentrations in serum, saliva and capillary whole blood among cases
and controls. Fig. 1a (Cases); Fig. 1b (Control).
Table 2. Mean difference (Bias) in glucose concentration between the various
samples among the diabetics and non-diabetics.
Samples Mean Difference (Bias) CI Effect Size (Cohen’s d) p-value
FSEG vs. FSLG
DM 14.91 13.16e16.65 1.78 <0.0001
Non-DM 4.62 4.19e5.05 1.76 <0.0001
FSEG vs. FCWBG
DM 0.16 1.54e1.91 0.01 0.974
Non-DM -0.005 0.43e0.42 0.001 0.978
FCWBG vs. FSLG
DM 14.7 12.96e16.44 1.79 <0.0001
Non-DM 4.63 4.20e5.06 1.76 <0.0001
DM ¼ Diabetes Mellitus, CI ¼ Confidence Interval; FSEG: fasting serum glucose; FSLG: fasting sali-
vary glucose; FCWBG: fasting capillary whole blood glucose.
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FCWBG concentration was significantly smaller in both diabetic and non-diabetes
patients.
A strong and significant positive correlation between FSLG and FSEG (r ¼ 0.890, p
< 0.0001) (Fig. 2a) and FCWBG concentration (r ¼ 0.870, p < 0.0001) (Fig. 2b)
among participants.
As shown in Fig. 3, the area under the curve (AUC) obtained for the diagnosis and
identification of participants with diabetes mellitus was 99.8% for FSEG, 91.0% for
Fig. 2. Correlation of saliva with serum and capillary whole blood glucose concentrations among study
participants. Fig. 1a (correlation between salivary glucose and serum glucose levels); Fig. 1b (correlation
between salivary glucose and capillary whole blood glucose levels).
Fig. 3. ROC curves for salivary, serum and capillary whole blood glucose concentrations for diagnosis
of diabetes mellitus.
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FSLG and 100.0% for FCWBG. These percentage accuracies were statistically sig-
nificant (p < 0.0001).
Table 3 shows the diagnostic performance of salivary, serum and capillary whole
blood glucose concentrations for DM diagnosis. After an ROC analysis, a cut-off
(threshold) value 0.5mmol, a sensitivity of 80.0% and a specificity of 95.0% for
FSLG was obtained for the prediction and identification of patients with DM.
Conversely, at a threshold value 6.8 mmol/L, sensitivity of 99.0% and specificity
of 100.0% for FSEG and a threshold value 6.9 mmol/L, sensitivity of 100.0% and
specificity of 100.0% for FCWBG was obtained for the prediction and identification
of patients with DM.
4. Discussion
Diabetic mellitus is a global chronic condition associated with a huge metabolic
nightmare. Early identification is a key to diagnosis and management to avert future
cardiovascular events [3]. The use of saliva as a non-invasive measure of glucose
levels among diabetes patients is gaining most stands despite the widely used routine
blood glucose estimations. For the first time in a Ghanaian population we compared
the diagnostic performance, and the correlation between fasting glucose levels in the
saliva, serum and whole blood among diabetes and non-diabetes patients.
In agreement with other studies, the intriguing but expected findings of this present
study were the significantly increased mean levels of FSLG, FSEG and FCWBG in
Table 3. Diagnostic performance of salivary, serum and whole blood glucose
concentrations for diabetes diagnosis.
Markers Sensitivity Specificity TP TN FP FN AUC (95% CI)
FSEG (mmol/l) 99.8(99.2e100.0)
>6.7 99.0% 100.0% 78 55 4 1
>6.8 99.0% 100.0% 78 59 0 1
>7.1 97.0% 100.0% 77 59 0 2
FSLG (mmol/l) 91.0(88.0e94.0)
>0.4 86.0% 85.0% 50 50 9 11
>0.5 80.0% 95.0% 63 56 3 16
>0.6 73.0% 98.0% 58 56 1 21
FCWBG (mmol/l) 100.0(99.0e100.0)
>6.8 100.0% 95.0% 78 56 3 0
>6.9 100.0% 100.0% 78 59 0 0
>7.1 97.0% 100.0% 76 59 0 2
AUC: Area Under Curve, TP: True Positive, TN: True Negative, FP: False Positive, FN: False Negative,
CI: Confidence Interval; FSEG: fasting serum glucose; FSLG: fasting salivary glucose; FCWBG: fasting
capillary whole blood glucose.
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diabetes patients compared to non-diabetes controls. Particularly for FSLG and
FSEG, case-control studies among Indian population [9, 12, 13], have reported an
increased level in diabetes compared to non-diabetes controls. In general, increased
levels of blood glucose in type II diabetes mellitus (T2DM) has been associated with
insulin resistance and large amount of glucose becomes available in blood and
saliva. The probable mechanism that underpins the increased salivary glucose
among diabetes patients has commonly been due to modifications in permeability
of glandular tissues, which results in basement membrane abnormalities of parotid
gland and oversecretion of glucose from the parotid duct [18]. In an experimental
diabetic rat model the ultrastructure of parotid gland cells had swollen intracytoplas-
mic mitochondria without visible cristae [19].
Alterations in the salivary flow and composition of saliva in diabetes patients have
been reported in previous studies [20, 21]. In this present study, FSEG and FCWBG
levels were significantly higher compared to salivary glucose while there was no sta-
tistically significant difference between FSEG compared to FCWBG levels in both
diabetes and non-diabetes mellitus controls. This concur with several case-control
studies among the Indian [9, 12, 13], and Chinese population [17]. The mechanisms
which underlie the lower levels of glucose in saliva compared to that in serum and
capillary whole blood among diabetes patients in this present study is not self-
understood however, this could be influenced by the water intake, the environment
factor, mood and anti-diabetic medications.
A significantly positive correlation between salivary glucose and blood glucose has
been reported by several studies [12, 13, 14, 15]. This is consistent with the findings
of this present study, which also found a strong positive and significant correlation
between FSLG and FSEG as well as FCWBG. This indicates that FSLG may serve
as an alternative and reliable measure of blood glucose levels. The coefficient of
determination explained that FSLG levels contributed to about 80% of the variations
in FSEG and FCWBG levels (Fig. 2). Increase in salivary glucose with increasing
serum and capillary glucose could be explained by several pathways. For instance,
high blood glucose levels has been linked to increased advanced glycosylation end
(AGEs) products formation, and other by-products, which increases the permeability
by chemically binding to extracellular matrix proteins to cause basement membrane
alteration and endothelial dysfunction [12]. The increased passage of glucose from
the blood into the saliva occurs as a result of an increased permeability caused by
other glucose product, such as diacylglycerol, sorbitol, and fructose-6-phosphate,
which are formed during chronic high glucose levels [12]. A study reported that
the increased permeability of basement membrane of parotid glands may result to
an increased leakage of smaller molecules like glucose into whole saliva through
gingival crevices [22].
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Based on the strong significant correlations observed between salivary glucose and
blood glucose concentrations, we further evaluated its diagnostic and predictive per-
formance. At 0.5 mmol/l for FSLG, sensitivity and specificity of 80.0% and 95.0%
respectively were recorded at an overall accuracy of 91% in this present study. In a
matched case-control study by Shashikanth et al. [23] among diabetes patients in an
Indian population, using salivary glucose yielded a 100% sensitivity, 78% specificity
and 89% accuracy (area under the curve). Compared to our study, the area under the
curve (accuracy) reported by Shashikanth and colleagues was similar. However,
there were disparities in the percentage sensitivity and specificity in this present
study compared to that reported by Shashikanth et al. [23], which we speculate could
probably due to difference in fasting time, sample size, and different in sample esti-
mation among other factors. The previous study by Shashikanth et al. [23] recruited
smaller sample participants and took samples at 2 h postprandial while we used a
larger sample and collected 8 to12 h fasting samples. Further studies are needed
to evaluate if a difference exist between salivary glucose levels 2 h post-prandial
and 8 to 12 h fasting glucose levels.
In this present study the diagnostic performance of blood glucose levels, that is,
FSEG and FCWBG were similar with a threshold range of 6.8e6.9 mmol/l, sensi-
tivity range of 99e100.0% and a specificity range of 100-100%. The higher diag-
nostic yield observed for both FSEG and FCWBG in the diagnosis and
identification of diabetes in this present study is as expected. This makes blood
glucose measure of DM more reliable compared to salivary glucose. The probable
explanation could be due to the increased levels of glucose in blood compared to
saliva observed in this study. However, the diagnostic accuracies and specificities
as well as correlations yielded for FSLG, FSEG and FCWBG are comparable sug-
gesting that salivary glucose could be used in addition to serum and capillary blood
glucose for diagnosis and monitoring diabetes. However, when utilizing salivary
glucose to monitor diabetes patients’, factors such as water intake, the environment
factor, mood and anti-diabetes medication must be considered. Although, sampling
saliva is non-invasive and can easily be obtained without expertise compared to
blood glucose sampling, there is the need to improve the sensitivity of saliva for
glucose determination by using a high throughput assay method. Developing
more sensitive methods for salivary glucose determination will add to knowledge
and increase innovative approach to diagnosis and self-management of DM.
Aside the interesting findings of this present study, there are some limitation that
would need improvement for further studies. Firstly, subject population size was
small and thus further studies will need a large sample to validate the findings of
this study. Secondly, the measurement of fasting capillary blood glucose was
different from salivary and serum glucose, which might introduce the methodology
difference, hence further studies is needed to correct this limitation by using the same
method estimation. Although our findings are consistent with the findings of several
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published articles, we recommend evaluation of salivary glycated hemoglobin
(HbA1c) in comparison with salivary glucose levels 2 h post-prandial in a large pop-
ulation Cohort study.
In conclusion, fasting salivary glucose level increased with increases in serum and
capillary blood glucose levels. However, from the diagnostic point of view, fasting
salivary glucose does not yield enough diagnostic and predictive accuracy compared
to serum and capillary whole blood glucose. Meanwhile salivary glucose can be used
in addition to blood glucose as a potentially useful non-invasive tool to monitor gly-
cemic control among patients with type 2 diabetes mellitus if its method of estima-
tion is improved.
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